Wearable Injectors Market Size, Share, Growth and Trend Analysis Report, 2018 to 2025
by Susan Hill Business ConsultantThe
global wearable injectors market is anticipated to reach
USD 11.3 billion by 2025, according to a new report by Grand View Research,
Inc. The market is expected to witness lucrative growth during the forecast
period owing to technological advancements in wearable injectors coupled with
rising demand for round-the-clock monitoring. The paradigm shift towards
self-administration of injectable is expected to drive the market during the
forecast period. In addition, increasing awareness and rising adoption of
wearable injectors are expected to assist in growth.
Technological
advancements in wearable injectors, such as Bluetooth integrated wearable
injectors, enable sending alerts to patients, such as injection reminders, and
provide patients access to data regarding their therapy regime. Also, optional
smart functionality provides connectivity to the healthcare network. Some of
these devices have buttons that are accessible through clothing, and others
prevent accidental activation. They also have audio and visual status
indicators or signals. Patients can self-administer drugs subcutaneously in
less time and with minimal effort as compared to intravenous or other routes.
Patients are not required to visit any healthcare provider for administration.
Prevalence
of lifestyle-associated diseases, such as diabetes and hypertension, is
expected to increase during the forecast period. These diseases demand
round-the-clock monitoring of various physiological parameters, such as blood
pressure and blood sugar levels. Thus, integration of healthcare data with
wearable injectors, which gets forwarded to physicians or doctors giving them
real-time access with minimal errors, is expected to boost the wearable
injectors market.
Further Key
Findings from the Study Suggest:
- The on-body
segment held lucrative market share in 2016, owing to growing preference
of patients for adhesive patches that release the drug easily and can be
worn on the skin
- The
motor-driven segment is expected to register the highest growth over the
forecast period owing to increasing demand from hospitals, clinics, retail
chain stores, and pharmacies
- The oncology
segment is expected to gain the largest market share due to increasing
incidence of cancer worldwide
- North America
is expected to dominate the wearable injectors market over the forecast
period due to rising demand for innovative Information Technology (IT)
solutions to streamline workflow and increasing regulatory requirements to
ensure patient safety
- Some of the key
players in wearable injectors market are Becton, Dickinson and Company;
Johnson & Johnson Services, Inc.; F. Hoffmann-La Roche Ltd.; Unilife
Corporation; SteadyMed Therapeutics, Inc.; Amgen, Inc.; Insulet
Corporation; Enable Injections; West Pharmaceutical Services, Inc.; and CeQur
SA.
Access full
research report on global wearable injectors market:
www.grandviewresearch.com/industry-analysis/wearable-injectors-market
Sponsor Ads
Created on Sep 19th 2019 07:58. Viewed 447 times.